Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm - eBioMedicine
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart | Future Medicinal Chemistry
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Nature Reviews Drug Discovery
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19 | SpringerLink
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
Comparison of different chemically modified inhibitors of miR-199b in vivo - ScienceDirect
Antagomir - an overview | ScienceDirect Topics
Cells | Free Full-Text | MicroRNA as a Potential Therapeutic Molecule in Cancer | HTML
Method of action for miRNA inhibitors: ( a ) antagomiR, ( b ) LNA, ( c... | Download Scientific Diagram
Frontiers | The Clinical Application of MicroRNAs in Infectious Disease
Noncoding RNA therapeutics — challenges and potential solutions | Nature Reviews Drug Discovery
Increased efficiency of modified antagomir and LNA chemistries in... | Download Scientific Diagram
MicroRNA therapeutics | Gene Therapy
MicroRNAs and other non-coding RNAs as targets for anticancer drug development | Nature Reviews Drug Discovery
MicroRNA-15a/16-1 Antagomir Ameliorates Ischemic Brain Injury in Experimental Stroke | Stroke
Therapeutic Implication of miRNA in Human Disease | IntechOpen
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart | Future Medicinal Chemistry
AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism - ScienceDirect
An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model | PLOS ONE
MicroRNA-15a/16-1 Antagomir Ameliorates Ischemic Brain Injury in Experimental Stroke | Stroke
Antagomir - an overview | ScienceDirect Topics
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
